InternationalUSRemember you can easily switch between MIP US and MIP International at any time

A daunting challenge for the UK IPO’s new boss


Tim Moss took over as chief executive of the UK IPO on May 1. Three months on, he talked to James Nurton about his ambitions, Brexit and being an “honest broker”

Tim Moss didn't have far to move when he was appointed chief executive of the UK IPO, in Newport, south Wales, having spent 14 years at Companies House in Cardiff, the last five of them as CEO. And it's not...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

RT @mdloney: Michael Shore, the lawyer behind Allergan’s controversial transfer of patents to a Native American tribe, vowed to "take a wre…

Nov 22 2017 07:33 ·  reply ·  retweet ·  favourite
ManagingIP profile

Our weekly IP news round-up includes stories about Finjan, Blue Coat, Fox Television, design patents, Polaroid, Fuj… https://t.co/dOtK14m74v

Nov 22 2017 02:01 ·  reply ·  retweet ·  favourite
ManagingIP profile

Confidentiality clubs becoming more common in Indian patent disputes https://t.co/VcVqY6V4CY The Delhi High Court r… https://t.co/qkhIzENcAw

Nov 22 2017 10:00 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

October 2017

Courts grapple with scope of patent protection

The Supreme Court’s decision in Actavis v Eli Lilly introduced a doctrine of equivalents and arguably also established a doctrine of prosecution history estoppel in the UK. We look at the law across Europe, and the impact the decision might have. Kingsley Egbuonu, Michael Loney and James Nurton set the scene



Most read articles

Supplements